2026 NPPES data Pulmonary Disease Physician NPI 1245339001 MD
Verify on CMS →

ALEKSEY BOGOLYUBOV, MD

Pulmonary Disease Physician in UTICA, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
727
Medicare Part D claims · 159 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
31%
generic claims · 69% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
78.7056/100
▼ 4 pts below national avg 83.1 · [object Object]
Industry payments
$781.71
40 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ALEKSEY BOGOLYUBOV, MD reported a CMS MIPS final score of 78.7056/100 — below the 83.1 national average — and filed 727 Medicare Part D claims in 2023.

78.7056/100
MIPS score · -4 vs avg
727
Part D claims, 2023
31%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ALEKSEY BOGOLYUBOV, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

79 27th percentile higher than 27% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ALEKSEY BOGOLYUBOV, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ALEKSEY BOGOLYUBOV, MD?

Near national average

NPI registry status

Active

Issued 09/21/2006

NPI 1245339001

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,271 US NPIs in this specialty

Medicare Part D claims

727 50% vs specialty avg

2023 prescription claims

Specialty avg: 1,457

MIPS final score

78.7056/100 4.39439999999999% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New York

How Pulmonary Disease Physician compares to other specialties among New York providers

New York providers

Pulmonary Disease Physician share within New York

1. Pulmonary Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pulmonary Disease Physician share within New York

Medicare quality performance — MIPS

ALEKSEY BOGOLYUBOV, MD's 2023 MIPS final score plotted against the Pulmonary Disease Physician national average

Near national average
MIPS Final Score
78.7056/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Pulmonary Disease Physician) — 78.7056/100 vs national avg 83.1

0%100%National avg83%78.7%
MIPS final score (Pulmonary Disease Physician) — 78.7056/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ALEKSEY BOGOLYUBOV, MD appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding MD credentials at 35 RIVERSIDE DR, UTICA, NY, 13502, with a listed phone of (315) 735-2294. NPI 1245339001 was issued on 09/21/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BOGOLYUBOV most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 727 prescription claims written by this provider, covering 159 Medicare beneficiaries and totaling roughly $370K in drug spend, split 69% brand-name and 31% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 78.7056/100 for the 2023 performance year (Quality 81.739, Cost 42.3807), compared with the national average of 83.1.

Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

35 RIVERSIDE DR
UTICA, NY 13502

Provider Details

NPI 1245339001
Specialty Pulmonary Disease Physician
Credentials MD
Gender Male
NPI Issued 09/21/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

78.7056
Final Score
Avg: 83.1
81.739
Quality
42.3807
Cost
99
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where ALEKSEY BOGOLYUBOV, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MVHS INC
UTICA, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ALEKSEY BOGOLYUBOV, MD. Source: openpaymentsdata.cms.gov.

Total received

$782

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to ALEKSEY BOGOLYUBOV, MD. To verify ALEKSEY BOGOLYUBOV, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

ALEKSEY BOGOLYUBOV, MD — brand share 69.0%
Specialty average (est.)

69% brand-name claims vs 31% generic, on 727 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

727
Total Claims
$370K
Total Drug Cost
159
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,139
Total Day Supply
32,099
Brand vs Generic
69% brand / 31% generic
Brand Drug Cost
$357K
Generic Drug Cost
$12K
Antibiotic Claims
47

Patient Demographics

Average Patient Age
72.0 years
Avg HCC Risk Score
1.78
Gender Split
54% female / 46% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ALEKSEY BOGOLYUBOV, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
134
Albuterol Sulfate Hfa
Albuterol Sulfate
129
Montelukast Sodium
50
Anoro Ellipta
Umeclidinium Brm/Vilanterol Tr
47
Symbicort
Budesonide/Formoterol Fumarate
36
Fluticasone-Salmeterol
Fluticasone Propion/Salmeterol
29
Roflumilast
29
Breo Ellipta
Fluticasone/Vilanterol
26
Prednisone
26
Spiriva Respimat
Tiotropium Bromide
26

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How ALEKSEY BOGOLYUBOV, MD fits within the Pulmonary Disease Physician landscape nationally.

9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider

ALEKSEY BOGOLYUBOV, MD's 727 claims are below the specialty average of 1,457.

Nearby Pulmonary Disease Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as BOGOLYUBOV.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ALEKSEY BOGOLYUBOV, MD's specialty?
ALEKSEY BOGOLYUBOV, MD specializes in Pulmonary Disease Physician and practices in UTICA, New York. Credentials: MD.
How much does ALEKSEY BOGOLYUBOV, MD prescribe under Medicare Part D?
In 2023, ALEKSEY BOGOLYUBOV, MD wrote 727 Medicare Part D claims totaling $370K in drug costs for 159 beneficiaries.
What is ALEKSEY BOGOLYUBOV, MD's Medicare quality score?
ALEKSEY BOGOLYUBOV, MD has a CMS MIPS Final Score of 78.7056/100 (Quality: 81.739, Cost: 42.3807). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ALEKSEY BOGOLYUBOV, MD located?
ALEKSEY BOGOLYUBOV, MD is located at 35 RIVERSIDE DR, UTICA, NY, 13502. Phone: (315) 735-2294.
What is ALEKSEY BOGOLYUBOV, MD's NPI number?
ALEKSEY BOGOLYUBOV, MD's National Provider Identifier (NPI) is 1245339001, issued on 09/21/2006.
Does ALEKSEY BOGOLYUBOV, MD prescribe more brand-name or generic drugs?
ALEKSEY BOGOLYUBOV, MD's prescribing is 69% brand-name and 31% generic drugs by claim count, with $357K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does ALEKSEY BOGOLYUBOV, MD prescribe most often?
Based on 2023 Medicare Part D data, ALEKSEY BOGOLYUBOV, MD's most frequently prescribed drugs include Trelegy Ellipta, Albuterol Sulfate Hfa, Montelukast Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ALEKSEY BOGOLYUBOV, MD accept Medicare?
ALEKSEY BOGOLYUBOV, MD appears in CMS Medicare data with 727 Part D claims and 159 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ALEKSEY BOGOLYUBOV, MD's credentials?
ALEKSEY BOGOLYUBOV, MD's NPI is 1245339001 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology